183 related articles for article (PubMed ID: 18842035)
1. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.
Tremblay MR; Nevalainen M; Nair SJ; Porter JR; Castro AC; Behnke ML; Yu LC; Hagel M; White K; Faia K; Grenier L; Campbell MJ; Cushing J; Woodward CN; Hoyt J; Foley MA; Read MA; Sydor JR; Tong JK; Palombella VJ; McGovern K; Adams J
J Med Chem; 2008 Nov; 51(21):6646-9. PubMed ID: 18842035
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
[TBL] [Abstract][Full Text] [Related]
4. Exo-cyclopamine--a stable and potent inhibitor of hedgehog-signaling.
Heretsch P; Büttner A; Tzagkaroulaki L; Zahn S; Kirchner B; Giannis A
Chem Commun (Camb); 2011 Jul; 47(26):7362-4. PubMed ID: 21589966
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of cyclopamine using a biomimetic and diastereoselective approach.
Giannis A; Heretsch P; Sarli V; Stössel A
Angew Chem Int Ed Engl; 2009; 48(42):7911-4. PubMed ID: 19591183
[No Abstract] [Full Text] [Related]
6. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified.
Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S
J Pharm Biomed Anal; 2010 Sep; 52(5):707-13. PubMed ID: 20236786
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity studies of cyclopamine derivatives.
Zhang J; Garrossian M; Gardner D; Garrossian A; Chang YT; Kim YK; Chang CW
Bioorg Med Chem Lett; 2008 Feb; 18(4):1359-63. PubMed ID: 18221872
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective synthesis of F-ring saturated estrone-derived inhibitors of Hedgehog signaling based on cyclopamine.
Zhang Z; Baubet V; Ventocilla C; Xiang C; Dahmane N; Winkler JD
Org Lett; 2011 Sep; 13(18):4786-9. PubMed ID: 21842835
[TBL] [Abstract][Full Text] [Related]
9. Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition.
El-Zaatari M; Grabowska AM; McKenzie AJ; Powe DG; Scotting PJ; Watson SA
Regul Pept; 2008 Feb; 146(1-3):131-9. PubMed ID: 17996964
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog antagonists cyclopamine and dihydroveratramine can be mistaken for each other in Veratrum album.
Wilson SR; Strand MF; Krapp A; Rise F; Herstad G; Malterud KE; Krauss S
J Pharm Biomed Anal; 2010 Nov; 53(3):497-502. PubMed ID: 20646889
[TBL] [Abstract][Full Text] [Related]
11. New developments in medulloblastoma treatment: the potential of a cyclopamine-lovastatin combination.
Bar EE; Stearns D
Expert Opin Investig Drugs; 2008 Feb; 17(2):185-95. PubMed ID: 18230052
[TBL] [Abstract][Full Text] [Related]
12. Autonomous Hedgehog signalling is undetectable in PC-3 prostate cancer cells.
McCarthy FR; Brown AJ
Biochem Biophys Res Commun; 2008 Aug; 373(1):109-12. PubMed ID: 18544338
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of several dietary alkaloids as weak inhibitors of hedgehog signaling.
Lipinski RJ; Dengler E; Kiehn M; Peterson RE; Bushman W
Toxicol Sci; 2007 Dec; 100(2):456-63. PubMed ID: 17728282
[TBL] [Abstract][Full Text] [Related]
14. One Hundred Faces of Cyclopamine.
Iovine V; Mori M; Calcaterra A; Berardozzi S; Botta B
Curr Pharm Des; 2016; 22(12):1658-81. PubMed ID: 26759083
[TBL] [Abstract][Full Text] [Related]
15. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of desmethylveramiline, a micromolar Hedgehog inhibitor.
Guerlet G; Spangenberg T; Mann A; Faure H; Ruat M
Bioorg Med Chem Lett; 2011 Jun; 21(12):3608-12. PubMed ID: 21592788
[TBL] [Abstract][Full Text] [Related]
17. I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs.
Chen JK
Nat Prod Rep; 2016 May; 33(5):595-601. PubMed ID: 26787175
[TBL] [Abstract][Full Text] [Related]
18. Biology-driven diversity: concept of focused diversity.
Kiselyov AS
Chem Biol Drug Des; 2006 Jul; 68(1):67-9. PubMed ID: 16923028
[No Abstract] [Full Text] [Related]
19. Cyclopamine and hedgehog signaling: chemistry, biology, medical perspectives.
Heretsch P; Tzagkaroulaki L; Giannis A
Angew Chem Int Ed Engl; 2010 May; 49(20):3418-27. PubMed ID: 20429080
[TBL] [Abstract][Full Text] [Related]
20. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway.
Gould A; Missailidis S
Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
